Cargando…
The cost and challenge of vaccine development for emerging and emergent infectious diseases
Autor principal: | Maslow, Joel N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129672/ https://www.ncbi.nlm.nih.gov/pubmed/30342926 http://dx.doi.org/10.1016/S2214-109X(18)30418-2 |
Ejemplares similares
-
Vaccine development for emerging virulent infectious diseases
por: Maslow, Joel N.
Publicado: (2017) -
Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018) -
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
por: Maslow, Joel N.
Publicado: (2017) -
Developing medical imaging AI for emerging infectious diseases
por: Huang, Shih-Cheng, et al.
Publicado: (2022) -
Nuanced risk assessment for emerging infectious diseases
por: Fisman, David N, et al.
Publicado: (2014)